Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 2, 2012Amyloid

Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study

View Full Paper
Ask AI
Bookmark
Share

Authors

LOLaura ObiciUniversity of PaviaACAndrea CorteseUniversity of PaviaALAlessandro LozzaUniversity of Pavia

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Obici et al. (2012) studied this question.

synapsesocial.com/papers/6a011b3b2ff633f365783aaehttps://doi.org/10.3109/13506129.2012.678508
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis.1995 · 206 citations
  2. 2Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses2008 · 136 citations
  3. 3Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models2010 · 184 citations
  4. 44 ′‐iodo‐4′‐Deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters2003 · 132 citations
  5. 5Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model2006 · 158 citations